ALLOGENICA
keyboard_backspaceBack to Home
Contact
47 boulevard du onze novembre 1918
69 625 Villeurbanne Cedex
France
COO
About us
Allogenica is a Lyon-based biotechnology company specialized in the development of an emerging class of cancer therapy, called CAR-T cells (Chimeric Antigen Receptor T-cells). Allogenica has developed a bioproduction platform that relies on the manipulation of hematopoietic stem cells and their derivatives with the aim of developing allogenic "off-the-shelf" CAR-T cells. Allogenica will offer the next-generation cancer treatment ready to use, at low cost and safer than current treatments, in order to treat all patients who need it.
Business offer
Activities
- Therapeutic Product
- Oncology
